SHANDONG XINHUA PHARMACEUTICAL CO LTD
SHANDONG XINHUA PHARMACEUTICAL CO LTD (China) holds 27 active US FDA Type II Drug Master Files and 5 inactive, has DMF or CEP filings on record for 22 active ingredients and is linked to 2 FDA-registered manufacturing sites. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “SHANDONG XINHUA PHARMACEUTICAL CO LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/shandong-xinhua-pharmaceutical-co-ltd
Overview
SHANDONG XINHUA PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 160 active FDA Type II Drug Master Files, covering 16 ALPHA-METHYL EPOXIDE (8-DM); 16 ALPHA-METHYL EPOXIDE (8DM); ABEMACICLIB; ABIRATERONE ACETATE; ABIRATERONE ACETATE (NON-STERILE); AFATINIB DIMALEATE.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which SHANDONG XINHUA PHARMACEUTICAL CO LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
SHANDONG XINHUA PHARMACEUTICAL CO LTD holds 27 active (32 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- LEVODOPA (II)Active2026-06-11
- BISMUTH SUBSALICYLATEActive2026-06-08
- OMEGA-3-ACID ETHYL ESTERS 90Active2025-09-11
- GLIMEPIRIDE (II)Active2024-09-04
- PREDNISOLONEActive2024-07-25
- CALCIUM POLYCARBOPHILActive2023-04-26
- HYDROCORTISONE ACETATEActive2022-12-06
- PREDNISONEActive2020-12-22
- SEVELAMER CARBONATEActive2020-11-02
- ETHYL ICOSAPENTATE 70Active2020-09-08
- ETHYL ICOSAPENTATE 98Active2020-03-10
- PREDNISONE ACETATEActive2020-02-18
- HYDROCORTISONEActive2018-10-04
- GLIMEPIRIDEActive2017-11-22
- DIPYRONE (METAMIZOLE SODIUM MONOHYDRATE)Active2016-10-19
- ASPIRIN/STARCH/POVIDONE DC-90Active2015-10-12
- IBUPROFEN SODIUMActive2014-06-10
- PHENOBARBITALActive2013-12-01
- CARBIDOPAActive2013-07-23
- ASPIRIN REFINEDActive2013-01-18
- MELOXICAMActive2010-12-08
- LEVODOPAActive2009-03-05
- IBUPROFENActive2001-07-03
- TRIMETHOPRIM USPActive1998-08-18
- CAFFEINE ANHYDROUSActive1998-07-10
- ASPIRINActive1994-01-20
- THEOPHYLLINEActive1982-07-28
- OMEGA-3-ACID-ETHYL ESTERSInactive2015-02-02
- AMLODIPINE BESYLATEInactive2012-05-25
- IRISQUINONEInactive2004-03-18
- HYDROCORTISONE ACETATEInactive2004-03-15
- HYDROCORTISONEInactive1995-07-27
Registered manufacturing sites (2)
Physical sites registered with the US FDA and resolved to SHANDONG XINHUA PHARMACEUTICAL CO LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to SHANDONG XINHUA PHARMACEUTICAL CO LTD in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this SHANDONG XINHUA PHARMACEUTICAL CO LTD?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.